Strikingly, this study also shows that certain CAFs may also be able to participate in antigen presentation, leading to direct killing of tumour-reactive CD8+ T cells in an antigen-specific manner through engagement of PD-L2 and Fas ligand [61]. Here, PDCD1LG2 is linked to neoplasm.